急性缺血性卒中机械取栓失败后补救性支架置入的多中心经验
该回顾性多中心研究分析了2010年9月至2015年12月16家综合卒中中心收治的591例颅内颈内动脉或大脑中动脉M1段闭塞行机械取栓的患者,其中148例(25.0%)取栓失败。比较失败后接受补救性支架置入(48例)与未进一步治疗(100例)的患者,结果显示支架组功能预后良好率更高(39.6% vs 22.0%,P=0.031),且未增加症状性颅内出血或死亡;校正后补救性支架置入仍与良好预后独立相关(OR 3.393,95%CI 1.192-9.655,P=0.022)。
要点
- 机械取栓失败患者中补救性支架置入与良好功能预后独立相关(OR 3.393)。
- 支架组良好预后率39.6%,高于未支架组的22.0%(P=0.031)。
- 支架组未增加症状性颅内出血(16.7% vs 20.0%)或死亡(12.5% vs 19.0%)。
核心结论
- 补救性支架置入与良好预后独立相关,且不增加症状性颅内出血或死亡。
- 作者认为对机械取栓失败的颈内动脉或大脑中动脉M1段闭塞可考虑补救性支架置入。
研究设计与样本
- 回顾性分析2010年9月至2015年12月16家综合卒中中心的队列。
- 共纳入591例颅内颈内动脉或大脑中动脉M1段闭塞行机械取栓的患者,其中148例(25.0%)取栓失败。
- 148例取栓失败患者分为补救性支架置入组48例和未进一步治疗组100例,比较临床与实验室特征及结局。
主要发现
- 补救性支架置入组取栓再通成功率为64.6%(31/48)。
- 补救性支架置入组良好预后(改良Rankin量表评分0-2分)率39.6%,高于未支架组的22.0%(P=0.031)。
- 补救性支架置入组症状性颅内出血发生率16.7%,未支架组20.0%(P=0.823);死亡率12.5% vs 19.0%(P=0.360)。
- 补救性支架置入组再通成功者良好预后率54.8%,与机械取栓再通成功组的55.4%相当。
- 校正其他因素后,补救性支架置入仍与良好预后独立相关(OR 3.393,95%CI 1.192-9.655,P=0.022)。
关键数值与推荐
- 机械取栓失败定义为颅内颈内动脉或大脑中动脉M1段闭塞未能再通。
- 良好预后定义为改良Rankin量表评分0-2分。
临床怎么用
- 作者认为对机械取栓失败的颈内动脉或大脑中动脉M1段闭塞可考虑补救性支架置入。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Effective rescue treatment has not yet been suggested in patients with mechanical thrombectomy (MT) failure. This study aimed to test whether rescue stenting (RS) improved clinical outcomes in MT-failed patients. METHODS: This is a retrospective analysis of the cohorts of the 16 comprehensive stroke centers between September 2010 and December 2015. We identified the patients who underwent MT but failed to recanalize intracranial internal carotid artery or middle cerebral artery M1 occlusion. Patients were dichotomized into 2 groups: patients with RS and without RS after MT failure. Clinical and laboratory findings and outcomes were compared between the 2 groups. It was tested whether RS is associated with functional outcome. RESULTS: MT failed in 148 (25.0%) of the 591 patients with internal carotid artery or middle cerebral artery M1 occlusion. Of these 148 patients, 48 received RS (RS group) and 100 were left without further treatment (no stenting group). Recanalization was successful in 64.6% (31 of 48 patients) of RS group. Compared with no stenting group, RS group showed a significantly higher rate of good outcome (modified Rankin Scale score, 0-2; 39.6% versus 22.0%; P=0.031) without increasing symptomatic intracranial hemorrhage (16.7% versus 20.0%; P=0.823) or mortality (12.5% versus 19.0%; P=0.360). Of the RS group, patients who had recanalization success had 54.8% of good outcome, which is comparable to that (55.4%) of recanalization success group with MT. RS remained independently associated with good outcome after adjustment of other factors (odds ratio, 3.393; 95% confidence interval, 1.192-9.655; P=0.022). Follow-up vascular imaging was available in the 23 (74.2%) of 31 patients with recanalization success with RS. The stent was patent in 20 (87.0%) of the 23 patients. Glycoprotein IIb/IIIa inhibitor was significantly associated with stent patency but not with symptomatic intracranial hemorrhage. CONCLUSIONS: RS was independently associated with good outcomes without increasing symptomatic intracranial hemorrhage or mortality. RS seemed considered in MT-failed internal carotid artery or middle cerebral artery M1 occlusion.
引用
- Chang Y, Kim BM, Bang OY, et al. Rescue Stenting for Failed Mechanical Thrombectomy in Acute Ischemic Stroke: A Multicenter Experience. Stroke. 2018. PMID: 29581342. doi:10.1161/STROKEAHA.117.020072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。